Magnovia Pharmaceutical Private Limited
About Magnovia Pharmaceutical Private Limited
Data last updated:
Magnovia Pharmaceutical Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52601MH2016PTC280341. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vishal Jaisingh Gawade and Sonali Sandeep Walunj.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Flat No 202 Balkrushna Arcade Chs Plot No 41 Sector 28 Nerul, Navi Mumbai, Maharashtra, India – 400706.
As per the financials filed for FY 2019, the company reported a revenue of ₹72.17 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹28.64 Lakh (net margin -39.7%) and EBITDA of -₹28.64 Lakh (EBITDA margin -39.7%).
The company has about 1 employee on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Magnovia Pharmaceutical Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No 202 Balkrushna Arcade Chs Plot No 41 Sector 28 Nerul, Navi Mumbai, Maharashtra, India – 400706
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Magnovia Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Magnovia Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Magnovia Pharmaceutical Private Limited, buy the company report.
Financials of Magnovia Pharmaceutical Private Limited
FY 2019 filings availableMagnovia Pharmaceutical Private Limited reported revenue of ₹72.17 Lakh (up 175% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue rose 175% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹28.64 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹28.64 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -39.7% | ||
| Net Profit Margin | -39.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Magnovia Pharmaceutical Private Limited, buy the company report.
Board of directors of Magnovia Pharmaceutical Private Limited
Magnovia Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Jaisingh Gawade | Director | 29 Apr 2016 | 10 Years 6 Months | Current |
| Sonali Sandeep Walunj | Director | 29 Apr 2016 | 10 Years 6 Months | Current |
| Dilip Madhukar Ramole Also directs: Sarva Kalyanum Healthcare LLP | Director | 14 Nov 2017 | 8 Years 11 Months | Current |
Peer comparison
Magnovia Pharmaceutical Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gufic Chem Private Limited | ₹72.48 Lakh (FY 2024) | -63.0% | Belgaum, Karnataka, India | |||
| Astranova Biotech Private Limited | ₹72.32 Lakh (FY 2025) | -25.0% | Pune, Maharashtra, India | |||
| Magnovia Pharmaceutical Private Limitedthis company | ₹72.17 Lakh (FY 2019) | -₹28.64 Lakh | -39.7% | 175.0% | 1 | Navi Mumbai, Maharashtra, India |
| Thrive Therapeutic Private Limited | ₹71.9 Lakh (FY 2025) | -82.0% | Thane, Maharashtra, India | |||
| Sentonssa Wellness Private Limited | ₹71.16 Lakh (FY 2024) | 0.0% | Siddhpur, Gujarat, India |
To see the full peer comparison of Magnovia Pharmaceutical Private Limited, buy the company report.
Auditor
Magnovia Pharmaceutical Private Limited is audited by G N C & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G N C & ASSOCIATES | FY 2018 | 136416W |
Shareholding
The shareholding of Magnovia Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Magnovia Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Magnovia Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Magnovia Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Magnovia Pharmaceutical Private Limited has a workforce of 1 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
GST
Magnovia Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Magnovia Pharmaceutical Private Limited, buy the company report.
Recent activity
Magnovia Pharmaceutical Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Dilip Madhukar Ramole was appointed as Director on 14 Nov 2017.
Frequently asked questions
Magnovia Pharmaceutical is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 April 2016 (10+ years old) and is registered under CIN U52601MH2016PTC280341.
Magnovia Pharmaceutical has 3 current directors:
- Vishal Jaisingh Gawade - Director
- Sonali Sandeep Walunj - Director
- Dilip Madhukar Ramole - Director
The latest financial statements of Magnovia Pharmaceutical on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2017 are in the company report.
No. Magnovia Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Magnovia Pharmaceutical is U52601MH2016PTC280341. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Magnovia Pharmaceutical was incorporated on 29 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Magnovia Pharmaceutical by revenue are Gufic Chem Private Limited, Astranova Biotech Private Limited, Thrive Therapeutic Private Limited, Sentonssa Wellness Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dilip Madhukar Ramole was appointed as Director on 14 Nov 2017. Sonali Sandeep Walunj was appointed as Director on 29 Apr 2016. Vishal Jaisingh Gawade was appointed as Director on 29 Apr 2016.
The registered office of Magnovia Pharmaceutical is at Flat No 202 Balkrushna Arcade Chs Plot No 41 Sector 28 Nerul, Navi Mumbai, Maharashtra, India – 400706.
Magnovia Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Magnovia Pharmaceutical is compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
